ABSTRACT
INTRODUCTION
Since no protein is completely inert when ectopically expressed, controlling transgene expression is a major challenge in biotechnology. The tight regulation of transgenes is a prerequisite for producing proteins of medical or economical interest that display some toxic or cytostatic properties for cells and organisms. In a more fundamental point of view, conditional expression systems will become a tool of choice, complementary to gene inactivation, to gain insight into the function of the unknown genes provided by systematic sequencing strategies. Two symmetrical approaches have been used to develop effector-driven expression systems: ( i ) the induction method, using ligand-dependent transcription machineries and ( ii ) the de-repression method, using repressors that can be shifted in a liganddependent manner into conformations unable to bind DNA. These latter tools more often derive from prokaryotic gene repressors and their corresponding operator DNA-binding sites, as the tetracyclin system (4) and the lactose operator-repressor system (10) .
The major limitation of the available inducible expression systems is the presence of a basal expression level in absence of active induction. This problem is likely a result of the spontaneous activity of the minimal promoters used in transgene constructions and by virtually any DNA fragment, due to the presence of cryptic binding sites for known or unknown transcription factors. This drawback is particularly obvious in the induction systems using cis -elements recognized by endogenous transcription factors like heatshock elements, nuclear receptor target sites or heavy-metal responsive promoters.
The present method is based on the use of a chimeric transcription factor containing the DNA-binding domain from the yeast Gal4 transcription factor (Gal-DBD), which is known to have no equivalent in higher eukaryotes, thus avoiding undesirable interferences with endogenous transcription regulators. In the present case, Gal-DBD is fused to the ligand-dependent transcription activation domain from the human estradiol receptor (ER)-LBD. The resulting chimeric transcription factor, named GalER, has long been shown to be capable of enhancing the activity of a synthetic Gal4-responsive promoter after the addition of estrogen (9) . The chimeric GalER factor presents two favorable features: ( i ) the presence of the activation domain from the carboxyterminal end of the ER (AF2), which is well defined and clearly estradiol-dependent and, in turn, ( ii ) the absence of the NH 2 -terminal domain of the ER (AF1), that displays some ligand-independent activity, which is unfavorable for the present purpose. However, the interest of such an estrogen-inducible system was greatly hindered by: ( i ) the presence of endogenous estrogens in body fluids or in the serums incorporated into cell culture media and ( ii ) by the spontaneous basal activity of Gal4-responsive promoters. To circumvent this problem, a synthetic Gal4-reponsive promoter has been constructed, with extremely low basal activity (2) . This optimized construct contains four palindromic Gal4-binding sites, linked to TATA and CCAAT boxes. However, we observed that this promoter still presents a significant level of activity in the absence of induction. Here, we present an additional improvement of this GalER system, allowing in the same time, the repression of the basal expression activity and a stimulation of greater amplitude.
MATERIALS AND METHODS

Materials
4-hydroxy-tamoxifen (4OH-tamoxifen) and estradiol were from Sigma (L'isle d'Abeau Chesnes, St. Quentin Fallavier, France). The reporter plasmid GalREnlslacZ was created by inserting a blunted fragment encoding the nuclear β -galactosidase ( β -gal) (1) into the Eco RV site of GC vector, which carries the Gal4-responsive promoter (2) . The Gal-chloramphenicol acetyl transferase (CAT) reporter plasmid is the pCAT-4 construct described previously (2) and was kindly provided by Dr. Meinrad Busslinger (Research Institute of Molecular Pathology, Vienna, Austria). The GalER expression plasmid, described by Webster et al. (9) , was kindly provided by Prof. Pierre Chambon (IGBMC Strasbourg, France).
Cell Culture
CHO-CH3S cells were maintained at 37°C in 5% CO 2 atmosphere, in F12-Dulbecco's modified Eagle medium (1:1) supplemented with 10% dextran charcoal-treated fetal bovine serum (FBS) (Life Technologies, Gaithersburg, MD, USA). Phenol Red ® was omitted because of its weak estrogenic activity. Medium was added with antibiotic/antimycotic solution composed of penicillin (500 U/ µ L), streptomycin (500 µ g/ µ L) and amphotericin (1.25 µ g/ µ L).
Transfections
Transfections were performed using a modified calcium phosphate precipitate method (2) . Cells were seeded in 6-well tissue culture plates at the Short Technical Reports density of 10 5 cells/well one day before transfection. One hour before adding calcium phosphate/DNA co-precipitate, cells were provided with fresh medium either with or without 4OH-tamoxifen (1 µ M). Twenty-four hours later, precipitate was removed by phosphate-buffered saline (PBS) washing and replaced by fresh medium containing either 4OH-tamoxifen or estradiol (1 µ M each). Cells were then grown for transient expression during 24 h and then submitted to either protein extraction for CAT assays or in situ Lac Z detection.
CAT Assays
Cells transfected with Gal-CAT and GalER, along with cytomegalovirus (CMV) β -gal as an internal control of transfection, were harvested after 48 h transient expression by scraping in chilled PBS containing 5% glycerol and centrifuged. Cell pellets were resuspended in 130 µ L of Tris-HCl, pH 7.8, containing 0.5% Triton ® X-100 and then frozen and thawed twice to improve lysis. Cellular debris were then eliminated by centrifugation, and 98-µ L aliquots of the supernatants were submitted to a 10-min incubation at 65°C to remove potential CAT inhibitors. Enzymatic activity was determinated using the following protocol: 98 µ L of cell extracts were put in presence of 20 µ L chloramphenicol, 5 mM in Tris-HCl (250 mM), pH 7.8, 0.5 µ L acetyl-CoA (both from Boehringer Mannheim GmbH, Mannheim, Germany) (4.54
. After a 3-h incubation at 37°C, reactions were stopped by adding 1 mL of 5 M urea. β -gal activities were determinated using the uncolored substrate of this enzyme, namely the ortho-nitro-phenyl-β -D -galactopyranoside (ONPG; Boehringer Mannheim GmbH) as follows: 30 µ L of lysate were incubated with 330 µ g ONPG (1.1 µ g/ µ L) in sodium phosphate buffer (pH 7.5). Reaction products were then assayed by spectrophotometric measurement at 450 nm. The relative CAT activities were expressed as CAT/ β -gal ratios. These ratios were compared to determine the fold activations of the system.
In Situ Detection of Lac Z-Positive Cells
Cells were initially fixed by a 15 -min incubation in 1% glutaraldehyde solution at room temperature. After washing in PBS, they were then incubated at 37°C for 90 min in a coloration solution containing 5-bromo-4-chloro-3-indyl-β -D -galactoside (X-gal; Life Technologies) as a colorless substrate of β -gal. After removing the coloration solution, cells were covered with 70% glycerol and observed by light microscopy.
RESULTS
The synthetic Gal4-responsive promoter with extremely low basal activity gen (GalRE-nlsLacZ). The nuclear concentration of Lac Z gene product further facilitates the detection of cells expressing Lac Z at low level. The Gal4-responsive promoter used in this construction was also to be activated by the chimeric transcription factor GalER in presence of estradiol and to display a low spontaneous activity (2). However, when introduced into Chinese hamster ovary (CHO) cells, we observed a significant activity even in absence of GalER, as demonstrated for instance, by in situ Lac Z staining after introduction of the GalRE-nlsLacZ plasmid (Figure 2A, column 1) . Such a background expression is likely to prohibit the use of this system for transgenes that can affect cell viability. When attempting to lower this basal activity, we found that in presence of GalER, 4OH-tamoxifen, a low-priced compound known for its ability to act as an antiestrogen by preventing estradiol-dependent transcription stimulation by ER (8), can significantly repress the level of background transcription. In CAT assays, done in presence of GalER, the sustained presence of 4OH-tamoxifen in the culture medium decreases, by more than half, the basal CAT activity (Figure 1, columns 1 and 3) . In addition, preincubation of cells with 4OH-tamoxifen before estrogen addition, leads to an unexpected enhancement of the stimulating action by estrogen. Combined with its lessening effect on the basal expression, this enhancing activity allows a dramatic increase of the amplitude of induction by estrogen. Indeed, estrogen addition at 24 h leads to a 5.6-fold activation of the Gal4-responsive promoter (Figure 1 , columns 1 and 2), while a 4OH-tamoxifen pretreatment from 0-24 h leads to a 19.4 -fold induction (Figure 1 , compare columns 3 and 4). In fact, this effect of 4OH-tamoxifen, which is very useful in the context of this system, could have been expected as a result of the previous observation that estradiol stimulation of the ER can be enhanced by previous addition of an anti-estrogen (5) .
We have also tested the validity of the system through the in situ β -gal detection assay. This alternative method was also used to determine if GalER is involved in mediating the effects of estradiol and 4OH-tamoxifen. As shown in Figure 2 , the induction by estradiol of the number of blue cells is estradiol receptor-dependent, considering the 4 -fold increase of Lac Z-positive cells induced by the presence of GalER (Figure 2A, compare columns 1 and 3) . One must notice, however, that the Lac Z staining is more intense upon stimulation by estradiol (data not shown), which might reflect a certain stimulating effect of estradiol. By itself, 4OH-tamoxifen seems to have an estrogen receptor-independent stimulating effect on transgene expression ( Figure  2A, column 2) . In presence of GalER, 4OH-tamoxifen appears capable of
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Vol. 27, No. 1 (1999) strongly inhibiting the basal expression of the system (Figure 2A, column 5 ). This 4OH-tamoxifen-induced repression by GalER is powerful because very few Lac Z-positive cells are detected after 4OH-tamoxifen pretreatment. For only 2 blue cells observed in one experiment in the presence of 4OH-tamoxifen, more than 800 were observed in an identical dish after replacement of 4OH-tamoxifen by estrogen. Moreover, considering that GalER and the Lac Z genes are carried by two different plasmids transfected in an equimolar ratio, one cannot exclude that these few cells are precisely those containing only the GalRE-nlsLacZ reporter plasmid. This drastic repressive effect of 4OH-tamoxifen cannot result from a mere negative effect of this compound on transfection efficiency or on cell viability, since it is clearly dependent on the presence of GalER (Figure 2A , compare columns 2 and 5). In addition, the effect of 4OH-tamoxifen is also fully reversible because it does not forbid the action of a subsequent estradiol treatment, as demonstrated by the high inducibility by estradiol after 4OH-tamoxifen withdrawal. Indeed, as previously observed in CAT assays, the stimulating action of estradiol appears of higher amplitude if cells containing both GalER and GalRE-nlsLacZ are pretreated with 4OH-tamoxifen. 4OH-tamoxifen pretreatment enhances the subsequent stimulating effect of estradiol, leading to a 2.4-fold increase of the number of Lac Z-positive cells ( Figure 2A , compare columns 3 and 4). The conditions used for Figure  2A , column 4, appear optimal for using GalER. Thus, as observed through the two techniques, CAT assays and X-gal staining, the use of tamoxifen greatly improves the use of the GalER/Gal4-RE system at two levels: ( i ) by reducing the background expression and ( ii ) by enhancing the induction step.
DISCUSSION
We show that the conditional expression system, based on the Gal4-responsive promoter constructed by Braselmann et al. (2) , can be strikingly improved by using the drug 4OH-tamoxifen. Fortuitously, we found that in addition to the enhanced inducibility by estradiol, 4OH-tamoxifen strongly decreases the basal activity of the Gal4-responsive promoter. This effect is clear in CAT assays and particularly obvious when using the in situ β -gal staining. The apparently more stringent regulation revealed by the latter method is probably inherent in the requirement for a threshold basal concentration of β -gal to be detectable. By itself, the repressive activity of 4OH-tamoxifen mediated by GalER, might appear surprising because contrary to other nuclear receptors, as for example the unliganded thyroid hormone (11) , reports on a repressive activity of the estradiol receptor are very few. Interestingly, it has been described that the AF2 domain of the estrogen receptor, present in GalER, can acquire a repressive activity through interaction with C/EBP (7). This finding is of particular interest considering that the Gal4-responsive promoter used in this system does contain a typical C/EBP target CCAAT box. It has also recently been shown that tamoxifen can promote the binding of co-repressors to the ER (6). Elucidating the molecular mechanism underlying the 4OH-tamoxifen-induced repression would be of fundamental interest. In the context of this work, this feature makes it possible to shift from a tight repression to a tight induction of the expression by using a single transcription factor (see Figure 3 for a synthetical scheme of the system). While only one out of the two activities of induction and repression is exploited at the same time in the other conditional expression systems, they are reunited in the present one, as a result of the dual activity of 4OH-tamoxifen. Taken together, the absence of Gal4-RE-binding factors and Gal4 consensus recognition sites in higher eukaryotes, the lack of cellular toxicity of 4OH-tamoxifen and of estradiol and the strong repressive activity of 4OH-tamoxifen-bound GalER make this system particularly useful for finely regulating transgene expression. As an ultimate test, we plan to use this system for controlling the expression of toxic transgenes. In conclusion, the improved system presented here allows the reconciliation of most requirements for an ideal inducible system; specifically, a strong activity upon induction and, more importantly, a low activity before induction.
INTRODUCTION
Many single-step systems are available to over-express and purify proteins fused to affinity tags, such as the Escherichia coli maltose binding protein (MBP), the Schistosoma japonicum glutathione S-transferase (GST), Histag, chitin binding domain (CBD), antibody epitope tags etc. (7) . The subsequent proteolytic cleavage of the fusion protein to separate the target protein from the affinity tag can be problematic in these systems (7) . Proteases are often inefficient, especially when the cleavage site is buried within the fusion
